rabbit polyclonal antibody against glur1 Search Results


96
PhosphoSolutions glur1 ser 845
Figure 2. MCH acts via Gi/o to reduce <t>GluR1</t> pSer 845 in the AcbSh. Graphs represent the ratio of phosphorylated signal to total protein signal for all treatments. A, Basal or SKF 81297-mediated GluR1 pSer 845 reduction by MCH is blocked by in vivo PTX treatment (n 12–15 slices per group). B, MCH-mediated reduction is not affected by inhibition of PLC–PKC pathway with U73122 (n 5 slices per group). *p 0.05, **p 0.01. Error bars indicate SEM.
Glur1 Ser 845, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+glur1/Anti-GluR1+Antibody/10__1523_slash_jneurosci__5858___09__2010-59-15-23
Average 96 stars, based on 1 article reviews
glur1 ser 845 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
NeuroMab mouse anti glua1 antibody
Figure 2. MCH acts via Gi/o to reduce <t>GluR1</t> pSer 845 in the AcbSh. Graphs represent the ratio of phosphorylated signal to total protein signal for all treatments. A, Basal or SKF 81297-mediated GluR1 pSer 845 reduction by MCH is blocked by in vivo PTX treatment (n 12–15 slices per group). B, MCH-mediated reduction is not affected by inhibition of PLC–PKC pathway with U73122 (n 5 slices per group). *p 0.05, **p 0.01. Error bars indicate SEM.
Mouse Anti Glua1 Antibody, supplied by NeuroMab, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+glur1/Anti-GluA1-GluR1+Glutamate+Receptor+Antibody/pmc09753999-259-4-9
Average 95 stars, based on 1 article reviews
mouse anti glua1 antibody - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
ImmunoStar inc anti-ampa receptor subunit 1 (glur1)
Figure 2. MCH acts via Gi/o to reduce <t>GluR1</t> pSer 845 in the AcbSh. Graphs represent the ratio of phosphorylated signal to total protein signal for all treatments. A, Basal or SKF 81297-mediated GluR1 pSer 845 reduction by MCH is blocked by in vivo PTX treatment (n 12–15 slices per group). B, MCH-mediated reduction is not affected by inhibition of PLC–PKC pathway with U73122 (n 5 slices per group). *p 0.05, **p 0.01. Error bars indicate SEM.
Anti Ampa Receptor Subunit 1 (Glur1), supplied by ImmunoStar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+glur1/rabbit+anti+glur1/pmc02886111-41-0-18
Average 90 stars, based on 1 article reviews
anti-ampa receptor subunit 1 (glur1) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Jackson Immuno primary antibody glua1
Synapse volumes increase correlatively during synaptic maturation. (A–D) Representative distribution of RIM1/2 and <t>GluA1</t> under stochastic optical reconstruction microscopy (STORM). Scale 2 μm in top panels and 500 nm in lower panels. (E–G) Volumes of identified synaptic RIM1/2, GluA1, and PSD-95 clusters across different developmental stages. Numbers in bars denote the synapse numbers. (H,I) Correlations between the volumes of GluA1 and RIM1/2 clusters (H) and the volumes of PSD-95 and RIM1/2 (I) within the same synapses. Linear regressions were conducted on synapses of DIV7 (gray circles and line) and DIV18 (dark blue circles and line). Data from synapses of DIV10 and 14 were plotted with dark yellow and dark red crosses. Also refer to , and for more details on correlations and statistics. All experiments were repeated ≥3 times.
Primary Antibody Glua1, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+glur1/AffiniPure+Fab+Fragment+Goat+Anti-Rabbit+IgG/pmc09171000-36-19-32
Average 93 stars, based on 1 article reviews
primary antibody glua1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc phospho glua1
Synapse volumes increase correlatively during synaptic maturation. (A–D) Representative distribution of RIM1/2 and <t>GluA1</t> under stochastic optical reconstruction microscopy (STORM). Scale 2 μm in top panels and 500 nm in lower panels. (E–G) Volumes of identified synaptic RIM1/2, GluA1, and PSD-95 clusters across different developmental stages. Numbers in bars denote the synapse numbers. (H,I) Correlations between the volumes of GluA1 and RIM1/2 clusters (H) and the volumes of PSD-95 and RIM1/2 (I) within the same synapses. Linear regressions were conducted on synapses of DIV7 (gray circles and line) and DIV18 (dark blue circles and line). Data from synapses of DIV10 and 14 were plotted with dark yellow and dark red crosses. Also refer to , and for more details on correlations and statistics. All experiments were repeated ≥3 times.
Phospho Glua1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+glur1/Phospho-AMPA+Receptor+1+(GluA1)+(Ser831)+Rabbit+mAb/pm40155780-267-65-68
Average 93 stars, based on 1 article reviews
phospho glua1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc rabbit anti glur1 antibody
Fig. 1. Expression of 5-HT1A receptor and AMPA <t>receptor</t> <t>subunit</t> <t>GluR1</t> in cortical neurons cultured for 3 days (A and B) and 14 days (C and D). (A) Neurons at 3 DIV were stained
Rabbit Anti Glur1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+glur1/AMPA+Receptor+1+(GluA1)+Rabbit+mAb/pm27702575-63-33-39
Average 96 stars, based on 1 article reviews
rabbit anti glur1 antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Synaptic Systems gria1
Primary antibodies used in the present study.
Gria1, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+glur1/182+011/pmc08103519-1-0-4
Average 94 stars, based on 1 article reviews
gria1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Alomone Labs rabbit anti glua1
Primary antibodies used in the present study.
Rabbit Anti Glua1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+glur1/Anti-GluR1+(GluA1)+(extracellular)+Antibody/pm24667327-230-4-17
Average 95 stars, based on 1 article reviews
rabbit anti glua1 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
Abbkine Inc rabbit polyclonal anti-glur1 antibody
Primary antibodies used in the present study.
Rabbit Polyclonal Anti Glur1 Antibody, supplied by Abbkine Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+glur1/anti+glur2+rabbit+polyclonal+antibody/pm38241230-80-140-149
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-glur1 antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc glua1
Primary antibodies used in the present study.
Glua1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+glur1/Phospho-AMPA+Receptor+1+(GluA1)+(Ser845)+Rabbit+mAb/pmc12077891__jci-135-186432-s206-148-39-40
Average 95 stars, based on 1 article reviews
glua1 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc mouse anti glur1
Primary antibodies used in the present study.
Mouse Anti Glur1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+glur1/Mouse+Anti-rabbit+IgG+(Conformation+Specific)+mAb/pmc05767545-91-28-62
Average 97 stars, based on 1 article reviews
mouse anti glur1 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

90
Upstate Biotechnology Inc rabbit anti-glur1
Immunocytochemical analysis of <t>GluR1</t> AMPAR subunit distribution on the surface of cultured hippocampal neurons. Representative immunostained neurons (14 d in vitro) are presented for the following conditions: control, untreated hippocampal neurons; DHPG, neurons treated with DHPG (100 μm, 10 min); DHPG + OV, neurons treated with DHPG in the presence of orthovanadate (1 mm); DHPG + MPEP, DHPG treatment was performed in the presence of the mGluR5 antagonist MPEP (10 μm); NMDA, neurons treated with NMDA (20 μm, 3 min); NMDA + OV, NMDA treatment was performed in the presence of orthovanadate (1 mm). Scale bars: top panels, 20 μm; enlarged areas, 5 μm.
Rabbit Anti Glur1, supplied by Upstate Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+glur1/anti+glur1/pmc06793648-128-24-32
Average 90 stars, based on 1 article reviews
rabbit anti-glur1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Figure 2. MCH acts via Gi/o to reduce GluR1 pSer 845 in the AcbSh. Graphs represent the ratio of phosphorylated signal to total protein signal for all treatments. A, Basal or SKF 81297-mediated GluR1 pSer 845 reduction by MCH is blocked by in vivo PTX treatment (n 12–15 slices per group). B, MCH-mediated reduction is not affected by inhibition of PLC–PKC pathway with U73122 (n 5 slices per group). *p 0.05, **p 0.01. Error bars indicate SEM.

Journal: Journal of Neuroscience

Article Title: Regulation of Nucleus Accumbens Activity by the Hypothalamic Neuropeptide Melanin-Concentrating Hormone

doi: 10.1523/jneurosci.5858-09.2010

Figure Lengend Snippet: Figure 2. MCH acts via Gi/o to reduce GluR1 pSer 845 in the AcbSh. Graphs represent the ratio of phosphorylated signal to total protein signal for all treatments. A, Basal or SKF 81297-mediated GluR1 pSer 845 reduction by MCH is blocked by in vivo PTX treatment (n 12–15 slices per group). B, MCH-mediated reduction is not affected by inhibition of PLC–PKC pathway with U73122 (n 5 slices per group). *p 0.05, **p 0.01. Error bars indicate SEM.

Article Snippet: For GluR1 protein detection, membranes were first blotted with the phospho-antibodies at 1:500 (rabbit polyclonal, GluR1 Ser 845 and Ser 831 antibodies from PhosphoSolutions).

Techniques: In Vivo, Inhibition

Figure4. SurfacelevelsofGluR1andmEPSCamplitudearereducedbyMCHinMSNsoftheAcbSh.A,Datarepresenttheratioof surface(cross-linked)tointernal(un-cross-linked)GluR1signal,andisnormalizedtountreatedcontrol.Treatmentconditionsare indicated below the graph along with representative surface and internal GluR1 signal (n 7–10 slices per group). B, C, Repre- sentativetracesbefore(B)andafter(C)bathapplicationofMCH(3M).D,E,Cumulativeprobabilityhistogramforamplitude(D) and interevent interval (E). n 8 neurons for mEPSC recordings; *p 0.05., **p 0.01. Error bars indicate SEM.

Journal: Journal of Neuroscience

Article Title: Regulation of Nucleus Accumbens Activity by the Hypothalamic Neuropeptide Melanin-Concentrating Hormone

doi: 10.1523/jneurosci.5858-09.2010

Figure Lengend Snippet: Figure4. SurfacelevelsofGluR1andmEPSCamplitudearereducedbyMCHinMSNsoftheAcbSh.A,Datarepresenttheratioof surface(cross-linked)tointernal(un-cross-linked)GluR1signal,andisnormalizedtountreatedcontrol.Treatmentconditionsare indicated below the graph along with representative surface and internal GluR1 signal (n 7–10 slices per group). B, C, Repre- sentativetracesbefore(B)andafter(C)bathapplicationofMCH(3M).D,E,Cumulativeprobabilityhistogramforamplitude(D) and interevent interval (E). n 8 neurons for mEPSC recordings; *p 0.05., **p 0.01. Error bars indicate SEM.

Article Snippet: For GluR1 protein detection, membranes were first blotted with the phospho-antibodies at 1:500 (rabbit polyclonal, GluR1 Ser 845 and Ser 831 antibodies from PhosphoSolutions).

Techniques:

Synapse volumes increase correlatively during synaptic maturation. (A–D) Representative distribution of RIM1/2 and GluA1 under stochastic optical reconstruction microscopy (STORM). Scale 2 μm in top panels and 500 nm in lower panels. (E–G) Volumes of identified synaptic RIM1/2, GluA1, and PSD-95 clusters across different developmental stages. Numbers in bars denote the synapse numbers. (H,I) Correlations between the volumes of GluA1 and RIM1/2 clusters (H) and the volumes of PSD-95 and RIM1/2 (I) within the same synapses. Linear regressions were conducted on synapses of DIV7 (gray circles and line) and DIV18 (dark blue circles and line). Data from synapses of DIV10 and 14 were plotted with dark yellow and dark red crosses. Also refer to , and for more details on correlations and statistics. All experiments were repeated ≥3 times.

Journal: Frontiers in Synaptic Neuroscience

Article Title: Correlative Assembly of Subsynaptic Nanoscale Organizations During Development

doi: 10.3389/fnsyn.2022.748184

Figure Lengend Snippet: Synapse volumes increase correlatively during synaptic maturation. (A–D) Representative distribution of RIM1/2 and GluA1 under stochastic optical reconstruction microscopy (STORM). Scale 2 μm in top panels and 500 nm in lower panels. (E–G) Volumes of identified synaptic RIM1/2, GluA1, and PSD-95 clusters across different developmental stages. Numbers in bars denote the synapse numbers. (H,I) Correlations between the volumes of GluA1 and RIM1/2 clusters (H) and the volumes of PSD-95 and RIM1/2 (I) within the same synapses. Linear regressions were conducted on synapses of DIV7 (gray circles and line) and DIV18 (dark blue circles and line). Data from synapses of DIV10 and 14 were plotted with dark yellow and dark red crosses. Also refer to , and for more details on correlations and statistics. All experiments were repeated ≥3 times.

Article Snippet: For co-staining of GluA1 and RIM1/2, as both antibodies were from rabbits, staining was performed separately and the first primary antibody (GluA1) was blocked and converted with a goat anti-rabbit Fab fragment (JacksonImmuno 111-007-003) for 2 h at RT, and then recognized by secondary antibodies.

Techniques: Microscopy

The heterogeneity of synaptic protein distribution increases with development. (A–D) Representative density maps of synaptic GluA1 at different developmental stages. Scale bars, 200 nm. (E–G) Normalized autocorrelation functions of RIM1/2 (E) , GluA1 (F) , and PSD-95 (G) . g a above 1 suggests a significant non-uniform distribution. (H–J) Developmental changes of nanocluster number (left), normalized density within nanocluster (middle), and nanocluster volume of RIM1/2 (H) , GluA1 (I) , and PSD-95 (J) . Numbers in bars denote the synapse numbers. Also refer to for more statistical details. All experiments were repeated ≥3 times.

Journal: Frontiers in Synaptic Neuroscience

Article Title: Correlative Assembly of Subsynaptic Nanoscale Organizations During Development

doi: 10.3389/fnsyn.2022.748184

Figure Lengend Snippet: The heterogeneity of synaptic protein distribution increases with development. (A–D) Representative density maps of synaptic GluA1 at different developmental stages. Scale bars, 200 nm. (E–G) Normalized autocorrelation functions of RIM1/2 (E) , GluA1 (F) , and PSD-95 (G) . g a above 1 suggests a significant non-uniform distribution. (H–J) Developmental changes of nanocluster number (left), normalized density within nanocluster (middle), and nanocluster volume of RIM1/2 (H) , GluA1 (I) , and PSD-95 (J) . Numbers in bars denote the synapse numbers. Also refer to for more statistical details. All experiments were repeated ≥3 times.

Article Snippet: For co-staining of GluA1 and RIM1/2, as both antibodies were from rabbits, staining was performed separately and the first primary antibody (GluA1) was blocked and converted with a goat anti-rabbit Fab fragment (JacksonImmuno 111-007-003) for 2 h at RT, and then recognized by secondary antibodies.

Techniques:

Correlation between presynaptic and postsynaptic protein heterogeneity in mature synapses. (A,B) Scatter plots for heterogeneity of GluA1 (A) and PSD-95 (B) against that of RIM1/2. All data points across all developmental stages could be fitted with linear functions as shown with lines. (C,D) Linear regressions of the relationships between heterogeneity of GluA1/PSD-95 and RIM1/2 at DIV7 (gray) and DIV18 (dark blue). (E) Relationship between heterogeneity and cluster volume of RIM1/2 at DIV7 (gray) and DIV18 (dark blue). Data points with cluster volume >1 × 10 7 nm 3 were fitted with linear functions. It is noted that g a of immature synapses was significantly lower than that of matured synapses. (F) Averaged g a of synapses with cluster volume of 1–4 × 10 7 nm 3 for immature (DIV7-10) and mature synapses (DIV18). Also refer to for more details. *** p < 0.001, t-test. All experiments were repeated ≥3 times.

Journal: Frontiers in Synaptic Neuroscience

Article Title: Correlative Assembly of Subsynaptic Nanoscale Organizations During Development

doi: 10.3389/fnsyn.2022.748184

Figure Lengend Snippet: Correlation between presynaptic and postsynaptic protein heterogeneity in mature synapses. (A,B) Scatter plots for heterogeneity of GluA1 (A) and PSD-95 (B) against that of RIM1/2. All data points across all developmental stages could be fitted with linear functions as shown with lines. (C,D) Linear regressions of the relationships between heterogeneity of GluA1/PSD-95 and RIM1/2 at DIV7 (gray) and DIV18 (dark blue). (E) Relationship between heterogeneity and cluster volume of RIM1/2 at DIV7 (gray) and DIV18 (dark blue). Data points with cluster volume >1 × 10 7 nm 3 were fitted with linear functions. It is noted that g a of immature synapses was significantly lower than that of matured synapses. (F) Averaged g a of synapses with cluster volume of 1–4 × 10 7 nm 3 for immature (DIV7-10) and mature synapses (DIV18). Also refer to for more details. *** p < 0.001, t-test. All experiments were repeated ≥3 times.

Article Snippet: For co-staining of GluA1 and RIM1/2, as both antibodies were from rabbits, staining was performed separately and the first primary antibody (GluA1) was blocked and converted with a goat anti-rabbit Fab fragment (JacksonImmuno 111-007-003) for 2 h at RT, and then recognized by secondary antibodies.

Techniques:

Evolvement of trans-synaptic nano-alignment during synaptic maturation. (A–D) Representative examples of synapses with RIM1/2 (red) and GluA1 (blue) co-labeled and imaged with STORM. Thick color denotes detected nanoclusters. Scale bar, 200 nm. (E) Normalized local density of GluA1 along with distances from RIM1/2 nanoclusters for synapses at different developmental stages. (F) , Averaged enrichment of GluA1 within 50 nm from peaks of RIM1/2 nanoclusters ( n = 85, 60, 30, 54, and 54 nanoclusters). The open bar represents the enrichment indices of synapses with the position of nanoclusters randomized within synaptic clusters. (G) Fraction of nanoclusters that were enriched with protein across the cleft. (H–J) Enrichment between RIM1/2 and PSD-95 for synapses at different developmental stages. * p < 0.05, ** p < 0.01, *** p < 0.001, one-way ANOVA with Tukey's multiple comparisons test in (F,I) , z -test in (G,J) . Also refer to for more statistical details. All experiments were repeated ≥3 times.

Journal: Frontiers in Synaptic Neuroscience

Article Title: Correlative Assembly of Subsynaptic Nanoscale Organizations During Development

doi: 10.3389/fnsyn.2022.748184

Figure Lengend Snippet: Evolvement of trans-synaptic nano-alignment during synaptic maturation. (A–D) Representative examples of synapses with RIM1/2 (red) and GluA1 (blue) co-labeled and imaged with STORM. Thick color denotes detected nanoclusters. Scale bar, 200 nm. (E) Normalized local density of GluA1 along with distances from RIM1/2 nanoclusters for synapses at different developmental stages. (F) , Averaged enrichment of GluA1 within 50 nm from peaks of RIM1/2 nanoclusters ( n = 85, 60, 30, 54, and 54 nanoclusters). The open bar represents the enrichment indices of synapses with the position of nanoclusters randomized within synaptic clusters. (G) Fraction of nanoclusters that were enriched with protein across the cleft. (H–J) Enrichment between RIM1/2 and PSD-95 for synapses at different developmental stages. * p < 0.05, ** p < 0.01, *** p < 0.001, one-way ANOVA with Tukey's multiple comparisons test in (F,I) , z -test in (G,J) . Also refer to for more statistical details. All experiments were repeated ≥3 times.

Article Snippet: For co-staining of GluA1 and RIM1/2, as both antibodies were from rabbits, staining was performed separately and the first primary antibody (GluA1) was blocked and converted with a goat anti-rabbit Fab fragment (JacksonImmuno 111-007-003) for 2 h at RT, and then recognized by secondary antibodies.

Techniques: Labeling

Fig. 1. Expression of 5-HT1A receptor and AMPA receptor subunit GluR1 in cortical neurons cultured for 3 days (A and B) and 14 days (C and D). (A) Neurons at 3 DIV were stained

Journal: Neuroscience research

Article Title: Roles of 5-HT 1A receptor in the expression of AMPA receptor and BDNF in developing mouse cortical neurons.

doi: 10.1016/j.neures.2016.09.008

Figure Lengend Snippet: Fig. 1. Expression of 5-HT1A receptor and AMPA receptor subunit GluR1 in cortical neurons cultured for 3 days (A and B) and 14 days (C and D). (A) Neurons at 3 DIV were stained

Article Snippet: To examine the localization of 5-HT1A receptor and GluR1 receptor, cortical neurons at 3 DIV and 14 DIV were incubated overnight at 4 ◦C with the rat anti-5-HT1A receptor antibody (1:1000 dilution) and rabbit anti-GluR1 antibody (#13185, 1:200 dilution, Cell Signaling Technology, U.S.A.), followed by the incubation with Alexa Fluor 488-conjugated goat anti-rat IgG antibody and Alexa Fluor 594-conjugated goat anti-rabbit IgG antibody for 1 h at room temperature.

Techniques: Expressing, Cell Culture, Staining

Fig. 2. Effects of 5-HT1A receptor agonist 8-OH-DPAT on the mRNA expression of BDNF and AMPA receptor subunits, GluR1 and GluR2, in cortical neurons in vitro. Neurons were

Journal: Neuroscience research

Article Title: Roles of 5-HT 1A receptor in the expression of AMPA receptor and BDNF in developing mouse cortical neurons.

doi: 10.1016/j.neures.2016.09.008

Figure Lengend Snippet: Fig. 2. Effects of 5-HT1A receptor agonist 8-OH-DPAT on the mRNA expression of BDNF and AMPA receptor subunits, GluR1 and GluR2, in cortical neurons in vitro. Neurons were

Article Snippet: To examine the localization of 5-HT1A receptor and GluR1 receptor, cortical neurons at 3 DIV and 14 DIV were incubated overnight at 4 ◦C with the rat anti-5-HT1A receptor antibody (1:1000 dilution) and rabbit anti-GluR1 antibody (#13185, 1:200 dilution, Cell Signaling Technology, U.S.A.), followed by the incubation with Alexa Fluor 488-conjugated goat anti-rat IgG antibody and Alexa Fluor 594-conjugated goat anti-rabbit IgG antibody for 1 h at room temperature.

Techniques: Expressing, In Vitro

Fig. 3. Effects of 5-HT1A receptor agonist 8-OH-DPAT on the mRNA expression of BDNF and AMPA receptor subunits, GluR1 and GluR2, in the frontal cortex (A), and Tph2 and 5-HTT

Journal: Neuroscience research

Article Title: Roles of 5-HT 1A receptor in the expression of AMPA receptor and BDNF in developing mouse cortical neurons.

doi: 10.1016/j.neures.2016.09.008

Figure Lengend Snippet: Fig. 3. Effects of 5-HT1A receptor agonist 8-OH-DPAT on the mRNA expression of BDNF and AMPA receptor subunits, GluR1 and GluR2, in the frontal cortex (A), and Tph2 and 5-HTT

Article Snippet: To examine the localization of 5-HT1A receptor and GluR1 receptor, cortical neurons at 3 DIV and 14 DIV were incubated overnight at 4 ◦C with the rat anti-5-HT1A receptor antibody (1:1000 dilution) and rabbit anti-GluR1 antibody (#13185, 1:200 dilution, Cell Signaling Technology, U.S.A.), followed by the incubation with Alexa Fluor 488-conjugated goat anti-rat IgG antibody and Alexa Fluor 594-conjugated goat anti-rabbit IgG antibody for 1 h at room temperature.

Techniques: Expressing

Primary antibodies used in the present study.

Journal: Biomedicines

Article Title: Inhibition of AKT/GSK3β/CREB Pathway Improves the Responsiveness to AMPA Receptor Antagonists by Regulating GRIA1 Surface Expression in Chronic Epilepsy Rats

doi: 10.3390/biomedicines9040425

Figure Lengend Snippet: Primary antibodies used in the present study.

Article Snippet: GRIA1 , Mouse , Synaptic systems (#182011) , 1:1000 (WB).

Techniques:

The effects of 3CAI co-treatment with perampanel (PER) and GYKI 52466 (GYKI) on surface expressions of GRIA1 and GRIA2 in chronic epilepsy rats. ( A ) Representative images for Western blot of total and membrane GRIA1 and GRIA2 expression levels. ( B – H ) Quantifications of total GRIA1 expression ( B ), membrane GRIA1 expression ( C ), membrane/total GRIA1 ratio ( D ), total GRIA2 expression ( E ), membrane GRIA2 expression ( F ), membrane/total GRIA2 ratio ( G ), and membrane GRIA1/GRIA2 ratio in the hippocampal tissues. Open circles indicate each individual value. Horizontal bars indicate mean value. Error bars indicate SEM ( *, # p < 0.05 vs. control (Cont) and vehicle (Veh)-treated animals, respectively; one-way ANOVA with post hoc Bonferroni’s multiple comparison).

Journal: Biomedicines

Article Title: Inhibition of AKT/GSK3β/CREB Pathway Improves the Responsiveness to AMPA Receptor Antagonists by Regulating GRIA1 Surface Expression in Chronic Epilepsy Rats

doi: 10.3390/biomedicines9040425

Figure Lengend Snippet: The effects of 3CAI co-treatment with perampanel (PER) and GYKI 52466 (GYKI) on surface expressions of GRIA1 and GRIA2 in chronic epilepsy rats. ( A ) Representative images for Western blot of total and membrane GRIA1 and GRIA2 expression levels. ( B – H ) Quantifications of total GRIA1 expression ( B ), membrane GRIA1 expression ( C ), membrane/total GRIA1 ratio ( D ), total GRIA2 expression ( E ), membrane GRIA2 expression ( F ), membrane/total GRIA2 ratio ( G ), and membrane GRIA1/GRIA2 ratio in the hippocampal tissues. Open circles indicate each individual value. Horizontal bars indicate mean value. Error bars indicate SEM ( *, # p < 0.05 vs. control (Cont) and vehicle (Veh)-treated animals, respectively; one-way ANOVA with post hoc Bonferroni’s multiple comparison).

Article Snippet: GRIA1 , Mouse , Synaptic systems (#182011) , 1:1000 (WB).

Techniques: Western Blot, Membrane, Expressing, Control, Comparison

Immunocytochemical analysis of GluR1 AMPAR subunit distribution on the surface of cultured hippocampal neurons. Representative immunostained neurons (14 d in vitro) are presented for the following conditions: control, untreated hippocampal neurons; DHPG, neurons treated with DHPG (100 μm, 10 min); DHPG + OV, neurons treated with DHPG in the presence of orthovanadate (1 mm); DHPG + MPEP, DHPG treatment was performed in the presence of the mGluR5 antagonist MPEP (10 μm); NMDA, neurons treated with NMDA (20 μm, 3 min); NMDA + OV, NMDA treatment was performed in the presence of orthovanadate (1 mm). Scale bars: top panels, 20 μm; enlarged areas, 5 μm.

Journal: The Journal of Neuroscience

Article Title: Tyrosine Phosphatases Regulate AMPA Receptor Trafficking during Metabotropic Glutamate Receptor-Mediated Long-Term Depression

doi: 10.1523/JNEUROSCI.4322-05.2006

Figure Lengend Snippet: Immunocytochemical analysis of GluR1 AMPAR subunit distribution on the surface of cultured hippocampal neurons. Representative immunostained neurons (14 d in vitro) are presented for the following conditions: control, untreated hippocampal neurons; DHPG, neurons treated with DHPG (100 μm, 10 min); DHPG + OV, neurons treated with DHPG in the presence of orthovanadate (1 mm); DHPG + MPEP, DHPG treatment was performed in the presence of the mGluR5 antagonist MPEP (10 μm); NMDA, neurons treated with NMDA (20 μm, 3 min); NMDA + OV, NMDA treatment was performed in the presence of orthovanadate (1 mm). Scale bars: top panels, 20 μm; enlarged areas, 5 μm.

Article Snippet: Individual subunits were immunoprecipitated using mouse anti-GluR2 (0.5 mg per slice; MAB397; Chemicon, Temecula, CA), rabbit anti-GluR2 (0.4 mg per slice; AB1768–25UG; Chemicon), or rabbit anti-GluR1 (0.4 mg per slice; catalog #07-660; Upstate Biotechnology, Lake Placid, NY) antibodies using the above-described procedure.

Techniques: Cell Culture, In Vitro

Regulation of tyrosine phosphorylation of AMPARs in hippocampal slices. A, AMPARs were immunoprecipitated from Triton X-100-solubilized membrane fractions (input) of hippocampal slices (400 μm) using a rabbit anti-GluR1–4 polyclonal antibody. The immunoprecipitated AMPAR proteins were identified on immunoblots with an anti-GluR1–4 guinea pig polyclonal antibody. Under our experimental conditions, all AMPAR subunits are immunoprecipitated from solubilized hippocampal slices. B, The immunoprecipitated AMPARs were immunoblotted with an HRP-conjugated anti-P-Y antibody. The anti-P-Y antibody identified a band at ∼105 kDa, which corresponds to the predicted molecular weight of AMPA receptor subunit proteins. This band was not detectable in control samples in which the rabbit anti-GluR1–4 antibody was replaced by the same dilution of the preimmune serum during immunoprecipitation. C, AMPARs were immunoprecipitated from control, DHPG- (100 μm), and/or orthovanadate- (OV; 1 mm) treated hippocampal slices. Slices were taken at the end of a 10 min DHPG application and after 30 min washout (or equivalent time points for conditions in which DHPG was not applied). Representative immunoblots showing the transient reduction of tyrosine phosphorylation of AMPAR subunits induced by DHPG. The positions of the molecular weight markers are indicated on the left. D, E, Quantitative analysis of tyrosine phosphorylation of AMPARs (D) and GluR1–4 protein content (E) of hippocampal slices after DHPG and/or orthovanadate treatments. After optimization of experimental conditions to the linear sensitivity range of the autoradiography film, the relative P-Y and GluR1–4 immunoreactivity was analyzed for each sample using densitometry in 6–11 independent experiments. D, The P-Y immunoreactivity was normalized to the GluR1–4 content of each sample. E, The GluR1–4 immunoreactivity was normalized to the β-actin content of each sample. The normalized P-Y (D) and GluR1–4 (E) immunoreactivities are presented as percentage of the corresponding untreated control values. Quantification showed significantly reduced level of tyrosine phosphorylation of AMPARs 10 min after DHPG treatment (D; **p < 0.02) without a significant change in the GluR1–4 content of hippocampal slices (E). In the presence of orthovanadate, there was no significant reduction in P-Y immunoreactivity at 10 min after DHPG treatment. Data are represented as mean ± SEM.

Journal: The Journal of Neuroscience

Article Title: Tyrosine Phosphatases Regulate AMPA Receptor Trafficking during Metabotropic Glutamate Receptor-Mediated Long-Term Depression

doi: 10.1523/JNEUROSCI.4322-05.2006

Figure Lengend Snippet: Regulation of tyrosine phosphorylation of AMPARs in hippocampal slices. A, AMPARs were immunoprecipitated from Triton X-100-solubilized membrane fractions (input) of hippocampal slices (400 μm) using a rabbit anti-GluR1–4 polyclonal antibody. The immunoprecipitated AMPAR proteins were identified on immunoblots with an anti-GluR1–4 guinea pig polyclonal antibody. Under our experimental conditions, all AMPAR subunits are immunoprecipitated from solubilized hippocampal slices. B, The immunoprecipitated AMPARs were immunoblotted with an HRP-conjugated anti-P-Y antibody. The anti-P-Y antibody identified a band at ∼105 kDa, which corresponds to the predicted molecular weight of AMPA receptor subunit proteins. This band was not detectable in control samples in which the rabbit anti-GluR1–4 antibody was replaced by the same dilution of the preimmune serum during immunoprecipitation. C, AMPARs were immunoprecipitated from control, DHPG- (100 μm), and/or orthovanadate- (OV; 1 mm) treated hippocampal slices. Slices were taken at the end of a 10 min DHPG application and after 30 min washout (or equivalent time points for conditions in which DHPG was not applied). Representative immunoblots showing the transient reduction of tyrosine phosphorylation of AMPAR subunits induced by DHPG. The positions of the molecular weight markers are indicated on the left. D, E, Quantitative analysis of tyrosine phosphorylation of AMPARs (D) and GluR1–4 protein content (E) of hippocampal slices after DHPG and/or orthovanadate treatments. After optimization of experimental conditions to the linear sensitivity range of the autoradiography film, the relative P-Y and GluR1–4 immunoreactivity was analyzed for each sample using densitometry in 6–11 independent experiments. D, The P-Y immunoreactivity was normalized to the GluR1–4 content of each sample. E, The GluR1–4 immunoreactivity was normalized to the β-actin content of each sample. The normalized P-Y (D) and GluR1–4 (E) immunoreactivities are presented as percentage of the corresponding untreated control values. Quantification showed significantly reduced level of tyrosine phosphorylation of AMPARs 10 min after DHPG treatment (D; **p < 0.02) without a significant change in the GluR1–4 content of hippocampal slices (E). In the presence of orthovanadate, there was no significant reduction in P-Y immunoreactivity at 10 min after DHPG treatment. Data are represented as mean ± SEM.

Article Snippet: Individual subunits were immunoprecipitated using mouse anti-GluR2 (0.5 mg per slice; MAB397; Chemicon, Temecula, CA), rabbit anti-GluR2 (0.4 mg per slice; AB1768–25UG; Chemicon), or rabbit anti-GluR1 (0.4 mg per slice; catalog #07-660; Upstate Biotechnology, Lake Placid, NY) antibodies using the above-described procedure.

Techniques: Immunoprecipitation, Western Blot, Molecular Weight, Autoradiography

DHPG-LTD is associated with changes in tyrosine phosphorylation of the GluR2 subunit. Membrane fractions were obtained from control and DHPG-treated (100 mm, 10 min) hippocampal slices. AMPAR subunits were solubilized and separated in RIPA buffer at 100°C, and the GluR1 and GluR2 proteins were individually immunoprecipitated using subunit-specific antibodies. The immunoprecipitated GluR1 and GluR2 proteins were immunoblotted with the HRP-conjugated anti-P-Y antibody to reveal which subunit is phosphorylated at tyrosine residues. Whereas the GluR1 shows only very weak P-Y immunoreactivity with or without DHPG treatment, the GluR2 subunit strongly reacted with the anti-P-Y antibody. DHPG treatment produced a marked reduction in the anti-P-Y labeling of the GluR2 subunit compared with untreated controls. Immunostaining with the GluR1 and GluR2 subunit-specific antibodies confirmed the complete separation and selective immunoprecipitation of these proteins. The same pattern was obtained in three independent experiments.

Journal: The Journal of Neuroscience

Article Title: Tyrosine Phosphatases Regulate AMPA Receptor Trafficking during Metabotropic Glutamate Receptor-Mediated Long-Term Depression

doi: 10.1523/JNEUROSCI.4322-05.2006

Figure Lengend Snippet: DHPG-LTD is associated with changes in tyrosine phosphorylation of the GluR2 subunit. Membrane fractions were obtained from control and DHPG-treated (100 mm, 10 min) hippocampal slices. AMPAR subunits were solubilized and separated in RIPA buffer at 100°C, and the GluR1 and GluR2 proteins were individually immunoprecipitated using subunit-specific antibodies. The immunoprecipitated GluR1 and GluR2 proteins were immunoblotted with the HRP-conjugated anti-P-Y antibody to reveal which subunit is phosphorylated at tyrosine residues. Whereas the GluR1 shows only very weak P-Y immunoreactivity with or without DHPG treatment, the GluR2 subunit strongly reacted with the anti-P-Y antibody. DHPG treatment produced a marked reduction in the anti-P-Y labeling of the GluR2 subunit compared with untreated controls. Immunostaining with the GluR1 and GluR2 subunit-specific antibodies confirmed the complete separation and selective immunoprecipitation of these proteins. The same pattern was obtained in three independent experiments.

Article Snippet: Individual subunits were immunoprecipitated using mouse anti-GluR2 (0.5 mg per slice; MAB397; Chemicon, Temecula, CA), rabbit anti-GluR2 (0.4 mg per slice; AB1768–25UG; Chemicon), or rabbit anti-GluR1 (0.4 mg per slice; catalog #07-660; Upstate Biotechnology, Lake Placid, NY) antibodies using the above-described procedure.

Techniques: Immunoprecipitation, Produced, Labeling, Immunostaining

Quantitative analysis of changes in GluR1 AMPA receptor distribution on the surface of hippocampal neurons after DHPG and NMDA treatments. The diagram summarizes pooled data from at least four experiments. *p < 0.05. Data are represented as mean ± SEM.

Journal: The Journal of Neuroscience

Article Title: Tyrosine Phosphatases Regulate AMPA Receptor Trafficking during Metabotropic Glutamate Receptor-Mediated Long-Term Depression

doi: 10.1523/JNEUROSCI.4322-05.2006

Figure Lengend Snippet: Quantitative analysis of changes in GluR1 AMPA receptor distribution on the surface of hippocampal neurons after DHPG and NMDA treatments. The diagram summarizes pooled data from at least four experiments. *p < 0.05. Data are represented as mean ± SEM.

Article Snippet: Individual subunits were immunoprecipitated using mouse anti-GluR2 (0.5 mg per slice; MAB397; Chemicon, Temecula, CA), rabbit anti-GluR2 (0.4 mg per slice; AB1768–25UG; Chemicon), or rabbit anti-GluR1 (0.4 mg per slice; catalog #07-660; Upstate Biotechnology, Lake Placid, NY) antibodies using the above-described procedure.

Techniques: